Dhumale, Pratibha
Nielsen, Jakob Vennike
Hansen, Anne Cathrine Schmidt
Burton, Mark
Beck, Hans Christian
Jørgensen, Mads Gustaf
Toyserkani, Navid Mohamadpour
Haahr, Martha Kirstine
Hansen, Sabrina Toft
Lund, Lars
Thomassen, Mads
Sørensen, Jens Ahm
Andersen, Ditte Caroline
Jensen, Charlotte Harken
Sheikh, Søren Paludan
Article History
Received: 10 May 2023
Accepted: 28 August 2023
First Online: 1 September 2023
Competing interests
: SPS is the CEO and owner of Blue Cell Therapeutics, Copenhagen, Denmark. The rest of the authors declare no competing interests.